Tranexamic OrPha 500 mg/5 ml
Tranexamic OrPha 500 mg/5 ml is a medicine authorised by Swissmedic under authorisation number 69007. The authorisation holder is OrPha Swiss GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 10 March 2023 and the authorisation is limited until 09 March 2028. ATC code B02AA02 places the medicine in the group Antihemorrhagics.
| Authorisation number | 69007 |
|---|---|
| Name | Tranexamic OrPha 500 mg/5 ml |
| Full name | Tranexamic OrPha 500 mg/5 ml, Injektionslösung |
| Authorisation holder | OrPha Swiss GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B02AA02 |
| First authorisation | 10 March 2023 |
| Authorisation validity | 09 March 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Tranexamic OrPha 500 mg/5 ml, Injektionslösung | B | 10 March 2023 |
| 2 | Tranexamic OrPha 1000 mg/10 ml, Injektionslösung | B | 10 March 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | Ampulle(n) | B02AA02 | 06.06.0. | B |
| 2 | 10 | Ampulle(n) | B02AA02 | 06.06.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Tranexamic OrPha 500 mg/5 ml authorised in Switzerland?
Yes. Tranexamic OrPha 500 mg/5 ml is authorised by Swissmedic under authorisation number 69007, data as of 01 September 2026. The authorisation is limited until 09 March 2028.
Which dispensing category does Tranexamic OrPha 500 mg/5 ml have?
Tranexamic OrPha 500 mg/5 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Tranexamic OrPha 500 mg/5 ml?
The authorisation holder is OrPha Swiss GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.